|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 21 out of 21 for Traf6

Category restricted to InteractionExperiment (x)

0.026s

Categories

Category: InteractionExperiment
« show all
Type Details Score
Interaction Experiment
Funakoshi-Tago M (2009)
Description: TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
•
•
•
•
•
Interaction Experiment
Wooff J (2004)
Description: The TRAF6 RING finger domain mediates physical interaction with Ubc13.
•
•
•
•
•
Interaction Experiment
Li S (2014)
Description: CHIP regulates osteoclast formation through promoting TRAF6 protein degradation.
•
•
•
•
•
Interaction Experiment
Yao K (2018)
Description: RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation.
•
•
•
•
•
Interaction Experiment
Ryu J (2005)
Description: Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function.
•
•
•
•
•
Interaction Experiment
Xia X (2011)
Description: NLRX1 negatively regulates TLR-induced NF-B signaling by targeting TRAF6 and IKK.
•
•
•
•
•
Interaction Experiment
Wang Y (2006)
Description: Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling.
•
•
•
•
•
Interaction Experiment
Chiou WF (2014)
Description: (+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation.
•
•
•
•
•
Interaction Experiment
Chen H (2006)
Description: Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination.
•
•
•
•
•
Interaction Experiment
Feng Y (2007)
Description: The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development.
•
•
•
•
•
Interaction Experiment
Panda S (2015)
Description: Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 Complexes.
•
•
•
•
•
Interaction Experiment
Ko R (2015)
Description: Glycogen synthase kinase 3 ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production.
•
•
•
•
•
Interaction Experiment
Zhu Z (2016)
Description: Cutting Edge: A Cullin-5-TRAF6 Interaction Promotes TRAF6 Polyubiquitination and Lipopolysaccharide Signaling.
•
•
•
•
•
Interaction Experiment
Li T (2017)
Description: The Ubiquitin E3 Ligase TRAF6 Exacerbates Ischemic Stroke by Ubiquitinating and Activating Rac1.
•
•
•
•
•
Interaction Experiment
Hu L (2017)
Description: Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.
•
•
•
•
•
Interaction Experiment
Lei H (2022)
Description: Ubiquitin-specific protease 47 regulates intestinal inflammation through deubiquitination of TRAF6 in epithelial cells.
•
•
•
•
•
Interaction Experiment
Liu X (2008)
Description: Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein.
•
•
•
•
•
Interaction Experiment
Lin YC (2013)
Description: The Tyrosine Kinase Syk Differentially Regulates Toll-like Receptor Signaling Downstream of the Adaptor Molecules TRAF6 and TRAF3.
•
•
•
•
•
Interaction Experiment
Takaesu G (2000)
Description: TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.
•
•
•
•
•
Interaction Experiment
Rim HK (2012)
Description: Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting TRAF6 and NF-B pathways and protects mice from lethal endotoxin shock.
•
•
•
•
•
Interaction Experiment
Masperone L (2022)
Description: The E3 Ubiquitin Ligase TRAF6 Interacts with the Cellular Prion Protein and Modulates Its Solubility and Recruitment to Cytoplasmic p62/SQSTM1-Positive Aggresome-Like Structures.
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom